Business Standard

World Coronavirus Dispatch: EU vaccine makers seek immunity from lawsuits

Morgan Stanley turns cautious on bonds, why globalisation will survive, ozone's effectiveness in neutralising Covid, and other pandemic-related news across the globe

A health worker in PPE collects a swab sample from a woman at a local health center to conduct tests for the coronavirus disease, amid the spread of the disease.
Premium

A health worker in PPE collects a swab sample from a woman at a local health center to conduct tests for the coronavirus disease, amid the spread of the disease

Yuvraj Malik New Delhi

The European pharmaceutical industry’s vaccines lobby has pushed the EU for exemptions that would protect its members from lawsuits if there are problems with any new coronavirus vaccines, according to people with knowledge. The pandemic has compressed into months vaccine research and development that can take years. Some potential vaccines are already at the phase-three testing stage — the last step before they come to regulators for approval. At the same time, governments around the world have poured cash into research and development to try to save lives and prevent economically crippling lockdowns. Read more here

Let’s look

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in